Aclaris Therapeutics, Inc. Assets, Current
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $97.77M.
- 2026-03-31: Assets, Current $110.23M.
- 2025-12-31: Assets, Current $96.32M.
- 2025-09-30: Assets, Current $100.59M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $97.77M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $110.23M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $96.32M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $100.59M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $104.20M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $108.79M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $125.95M 10-K · filed 2026-02-26 |
| 2024-09-30 | $132.33M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $117.64M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $135.34M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $128.86M 10-K · filed 2025-02-27 |
| 2023-09-30 | $123.07M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $132.94M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $184.36M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $231.55M 10-K · filed 2024-02-27 |
| 2022-09-30 | $256.57M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $259.35M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $190.88M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $205.03M 10-K · filed 2023-02-23 |
| 2021-09-30 | $205.78M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $241.26M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $134.50M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $57.49M 10-K · filed 2022-02-24 |
| 2020-09-30 | $58.00M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $70.95M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $82.71M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $83.80M 10-K · filed 2021-02-25 |
| 2019-09-30 | $145.37M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $137.89M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $156.81M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $179.50M 10-K · filed 2020-02-25 |
| 2018-09-30 | $145.52M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $171.17M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $192.26M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $200.22M 10-K · filed 2019-03-18 |
| 2017-09-30 | $234.12M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $175.75M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $157.35M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $138.56M 10-K · filed 2018-03-12 |
| 2016-09-30 | $85.59M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $95.64M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $86.83M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $86.52M 10-K · filed 2017-03-15 |
| 2015-09-30 | $39.36M 10-Q · filed 2015-12-03 |
| 2014-12-31 | $16.33M 10-K · filed 2016-03-23 |